Study of Etanercept in the Treatment of Psoriasis in Adult Subjects

NCT00121615 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

391

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Psoriasis

Interventions

DRUG: etanercept

Sponsor

Amgen

Collaborators

[object Object]